| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 05/12/2011 | US20110111056 Peptide dicer substrate agents and methods for their specific inhibition of gene expression |
| 05/12/2011 | US20110111044 Nanoparticle compositions for nucleic acids delivery system |
| 05/12/2011 | US20110111041 Bacterially derived intact minicells that encompass plasmid free functional nucleic acid for in vivo delivery to mammalian cells |
| 05/12/2011 | US20110111036 Intracellular antibody delivery |
| 05/12/2011 | US20110111034 Method and material for enhanced tissue-biomaterial integration |
| 05/12/2011 | US20110111030 Method of Producing Progenitor Cells from Differentiated Cells |
| 05/12/2011 | US20110111005 Biocompatible material and uses thereof |
| 05/12/2011 | US20110110986 High-yield activation of polymer surfaces for covalent attachment of molecules |
| 05/12/2011 | US20110110981 Orally Administerable Vaccine for Yersinia Pestis |
| 05/12/2011 | US20110110972 Stimulation of an immune response by enantiomers of cationic lipids |
| 05/12/2011 | US20110110970 Chimeric vaccines |
| 05/12/2011 | US20110110967 Gas57 mutant antigens and gas57 antibodies |
| 05/12/2011 | US20110110964 Immunogenic peptides and their use in transplantation |
| 05/12/2011 | US20110110962 Novel Immunoadjuvant Flagellin-Based Compounds and Use Thereof |
| 05/12/2011 | US20110110960 Mannose-6-phosphate receptor mediated gene transfer into muscle cells |
| 05/12/2011 | US20110110958 Compositions and methods for the treatment of neoplasia |
| 05/12/2011 | US20110110952 Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer |
| 05/12/2011 | US20110110951 Isolation of five novel genes coding for new fc receoptrs-type melanoma involved in the pathogenesis of lymphoma/melanoma |
| 05/12/2011 | US20110110949 Nesfatin-1 specific antibody and the use thereof, and nesfatin specific antibody and the use thereof |
| 05/12/2011 | US20110110944 Anti-alk1 antibodies and uses thereof |
| 05/12/2011 | US20110110937 Composition and method for introduction of rna interference sequences into targeted cells and tissues |
| 05/12/2011 | US20110110936 Anti-gcc antibody molecules and related compositions and methods |
| 05/12/2011 | US20110110935 Methods and Compositions for Increasing Iduronate 2-Sulfatase Activity in the CNS |
| 05/12/2011 | US20110110926 Compositions and methods for treating or preventing prostate cancer and for detecting androgen receptor variants |
| 05/12/2011 | US20110110918 Role of (de)acetylation in counteracting protein aggregation |
| 05/12/2011 | US20110110917 Human Aminoacyl-tRNA Synthetase Polypeptides Useful For The Regulation of Angiogenesis |
| 05/12/2011 | US20110110909 Human facilitating cells |
| 05/12/2011 | US20110110908 Treatment of disease conditions via administration of dna repair enzyme |
| 05/12/2011 | US20110110903 Cell fusion promoter and utilization of the same |
| 05/12/2011 | US20110110902 Means and methods for counteracting, delaying and/or preventing heart disease |
| 05/12/2011 | US20110110901 Methods of long-term culture of eukaryotic cells and uses thereof |
| 05/12/2011 | US20110110900 Novel adult progenitor cell |
| 05/12/2011 | US20110110899 Combined Chemical and Genetic Approaches for Generation of Induced Pluripotent Stem Cells |
| 05/12/2011 | US20110110897 Adult Human Cardiac-Derived Progenitor Cells |
| 05/12/2011 | US20110110896 Modulating levels of RNA-binding proteins for the treatment of breast cancer |
| 05/12/2011 | US20110110888 Scaffold Coated and/or Impregnated with at Least One Bioactive Agent for Tissue Repair and Other Medical Applications |
| 05/12/2011 | US20110110885 Bioactive Depside and Anthocyanin Compounds, Compositions, and Methods of Use |
| 05/12/2011 | US20110110860 Modulation of ldl receptor gene expression with double-stranded rnas targeting the ldl receptor gene promoter |
| 05/12/2011 | US20110110853 Primitive vascular progenitor cells and uses thereof |
| 05/12/2011 | US20110110852 Multivalent Antibodies and Uses Therefor |
| 05/12/2011 | US20110108644 Method of Making Demineralized Bone Particles |
| 05/12/2011 | US20110108420 Methods for production of proteins |
| 05/12/2011 | CA2779859A1 Method for expanding and/or preserving cells by means of gas enrichment of the culture medium |
| 05/12/2011 | CA2779726A1 Ex host maturation of germline stem cells |
| 05/12/2011 | CA2779701A1 Germline stem cell banking system |
| 05/12/2011 | CA2779632A1 Simian adenovirus and methods of use |
| 05/12/2011 | CA2779526A1 Truncated epiderimal growth factor receptor (egfrt) for transduced t cell selection |
| 05/12/2011 | CA2779396A1 Plants with improved nitrogen utilization and stress tolerance |
| 05/12/2011 | CA2779281A1 Catenae: serosal cancer stem cells |
| 05/12/2011 | CA2778234A1 Methods and compositions for modulating tau levels |
| 05/12/2011 | CA2777710A1 Episomal reprogramming with chemicals |
| 05/12/2011 | CA2777552A1 Cardiomyocyte production |
| 05/12/2011 | CA2775146A1 Somatic ovule specific promoter and methods of use |
| 05/12/2011 | CA2685964A1 Methods of fabrication and vascularization of thick three dimensional tissue constructs |
| 05/11/2011 | EP2319935A2 GnTIII (UDP-N-acetylglucosamine:Beta -D mannoside Beta (1,4)-N-acetylglucosaminyltransferase III) expression in plants |
| 05/11/2011 | EP2319934A2 GnTIII (UDP-N-acetylglucosamine:Beta -D mannoside Beta (1,4)-N-acetylglucosaminyltransferase III) expression in plants |
| 05/11/2011 | EP2319933A1 Universal chloroplast integration and expression vectors, transformed plants and products thereof |
| 05/11/2011 | EP2319929A1 IL-1 related polypeptides |
| 05/11/2011 | EP2319928A1 Dimeric thrombopoietin peptide mimetics binding to MP1 receptor and having thrombopoietic activity |
| 05/11/2011 | EP2319921A1 Novel protease and use thereof |
| 05/11/2011 | EP2319916A1 Cell capable of replicating novel hcv replicon, cell capable of replicating full-length hcv rna, and use of those cells |
| 05/11/2011 | EP2319915A1 A novel conditionally immortalized human proximal tubule cell line expressing functional influx and efflux transporters. |
| 05/11/2011 | EP2319914A1 Preparation and use of plant meristem cells with a high content of caffeic acid derivatives |
| 05/11/2011 | EP2319870A2 Human antibodies that bind human IL-12 and methods for producing |
| 05/11/2011 | EP2319547A2 Matrix for the production of ligaments, tendons and other tissue |
| 05/11/2011 | EP2319541A1 Factor VII or VIIA-like conjugates |
| 05/11/2011 | EP2319533A1 Immunity-inducing agent and method for detection of cancer |
| 05/11/2011 | EP2319528A2 Methods of increasing platelet and hematopoietic stem cell production |
| 05/11/2011 | EP2319301A2 Transgenic animals bearing human Ig lambda light chain genes |
| 05/11/2011 | EP2318833A1 Separation of blood cells from a blood sample |
| 05/11/2011 | EP2318536A2 Combination of two genetic elements for the control of the flower development of a dicotyldenous plant , its application in methods of detection and selection |
| 05/11/2011 | EP2318530A1 New influenza virus immunizing epitope |
| 05/11/2011 | EP2318520A2 Compositions for mesoderm derived isl1+ multipotent cells (imps), epicardial progenitor cells (epcs) and multipotent cxcr4+cd56+ cells (c56cs) and methods of use |
| 05/11/2011 | EP2318519A1 Purified mesenchymal stem cell compositions and methods of purifying mesenchymal stem cell compositions |
| 05/11/2011 | EP2318518A2 Cell-based method for rebuilding bone |
| 05/11/2011 | EP2318517A2 Process for cultivating cells |
| 05/11/2011 | EP2318516A1 Differentiation of pluripotent stem cells |
| 05/11/2011 | EP2318506A2 Materials and methods for cell growth |
| 05/11/2011 | EP2318434A1 Her2/neu specific t cell receptors |
| 05/11/2011 | EP2318019A1 Mesoangioblast-like cell as well as methods and uses relating thereto |
| 05/11/2011 | EP2030984B1 Sparc-derived cancer rejection antigen peptide and pharmaceutical comprising the same |
| 05/11/2011 | EP1574571B1 Germ-responsive promoter |
| 05/11/2011 | EP1449850B9 Human cdr-grafted antibodies and antibody fragments thereof |
| 05/11/2011 | EP1427856B1 Fusion proteins useful for detecting analytes |
| 05/11/2011 | EP1372786B1 Cytoprotection by phosphotyrosine |
| 05/11/2011 | EP0987325B1 Method for separating cells |
| 05/11/2011 | CN1946285B Methods for coupling resistance alleles in tomato |
| 05/11/2011 | CN1942585B Nucleic acid construct containing full-length genome of human hepatitis c virus, method for nucleic acid construct transferring into recombinant full-length virus genome replicative cell and method of producing hepatitis C virus particle |
| 05/11/2011 | CN1871354B Cotton alpha-globulin promoter for seed-specific expression of transgenes |
| 05/11/2011 | CN1829791B Skin regeneration system |
| 05/11/2011 | CN1692156B Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions |
| 05/11/2011 | CN1688695B New dendritic cell co stimulatory molecules |
| 05/11/2011 | CN102057037A Method for isolation of smooth muscle stem cell |
| 05/11/2011 | CN102056626A Detection and tratment of pancreatic, ovarian and other cancers |
| 05/11/2011 | CN102051378A Method for screening anti-HIV-1 (Human Immunodeficiency Virus) drugs with virus mRNA core transfer as target point |
| 05/11/2011 | CN102051367A Identification of populus euphratica olive PeCPK10 gene and function research thereof |
| 05/11/2011 | CN102051362A Interference RNA (Ribonucleic Acid) of targeted HPIP (hematopoietic PBX-interacting protein) gene, medical composition containing same and application thereof |
| 05/11/2011 | CN102051354A Microcapsule encapsulated with filamentous scaffolds as well as preparation method and applications thereof |
| 05/11/2011 | CN102051353A Spongiform stents-encapsulated microcapsules, preparation and application thereof |
| 05/11/2011 | CN102051351A Drought-resistance related key enzyme derived from Leymus chinensis (Trin.) Tzvel. as well as coding gene and application thereof |